ZVRA logo

Zevra Therapeutics (ZVRA) Total Liabilities

Annual Total Liabilities

$110.46 M
+$70.24 M+174.65%

31 December 2023

ZVRA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$121.78 M
+$9.85 M+8.80%

30 September 2024

ZVRA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+174.7%+70.3%
3 y3 years+42.3%+2134.9%
5 y5 years+18.4%+45.8%

ZVRA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1797.0%at high+2794.7%
5 y5 yearsat high+1797.0%at high+2794.7%
alltimeall timeat high+1797.0%-1.3%+2794.7%

Zevra Therapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$121.78 M(+8.8%)
June 2024
-
$111.93 M(+9.2%)
Mar 2024
-
$102.47 M(-7.2%)
Dec 2023
$110.46 M(+174.6%)
$110.46 M(+54.5%)
Sept 2023
-
$71.51 M(+93.2%)
June 2023
-
$37.02 M(+5.2%)
Mar 2023
-
$35.19 M(-12.5%)
Dec 2022
$40.22 M(+590.7%)
$40.22 M(+56.2%)
Sept 2022
-
$25.76 M(+2.9%)
June 2022
-
$25.02 M(+494.8%)
Mar 2022
-
$4.21 M(-27.8%)
Dec 2021
$5.82 M(-92.5%)
-
Dec 2021
-
$5.82 M(+6.9%)
Sept 2021
-
$5.45 M(-33.0%)
June 2021
-
$8.13 M(+31.5%)
Mar 2021
-
$6.18 M(-92.0%)
Dec 2020
$77.62 M(-8.6%)
$77.62 M(+5.6%)
Sept 2020
-
$73.53 M(-2.2%)
June 2020
-
$75.19 M(-3.1%)
Mar 2020
-
$77.56 M(-8.7%)
Dec 2019
$84.96 M
$84.96 M(+1.7%)
DateAnnualQuarterly
Sept 2019
-
$83.51 M(-11.7%)
June 2019
-
$94.56 M(-0.2%)
Mar 2019
-
$94.70 M(+1.5%)
Dec 2018
$93.31 M(-15.1%)
$93.31 M(-18.2%)
Sept 2018
-
$114.08 M(-2.9%)
June 2018
-
$117.55 M(-3.9%)
Mar 2018
-
$122.33 M(+11.2%)
Dec 2017
$109.97 M(+6.2%)
$109.97 M(+2.4%)
Sept 2017
-
$107.41 M(-0.8%)
June 2017
-
$108.33 M(-1.1%)
Mar 2017
-
$109.57 M(+5.8%)
Dec 2016
$103.58 M(+60.1%)
$103.58 M(-0.7%)
Sept 2016
-
$104.35 M(+0.0%)
June 2016
-
$104.30 M(-15.5%)
Mar 2016
-
$123.42 M(+90.7%)
Dec 2015
$64.71 M(+4.0%)
$64.71 M(-3.6%)
Sept 2015
-
$67.16 M(+6.5%)
June 2015
-
$63.08 M(-7.9%)
Mar 2015
-
$68.47 M(+10.0%)
Dec 2014
$62.22 M(+133.1%)
$62.22 M
Dec 2013
$26.70 M
-

FAQ

  • What is Zevra Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Zevra Therapeutics?
  • What is Zevra Therapeutics annual total liabilities year-on-year change?
  • What is Zevra Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly total liabilities year-on-year change?

What is Zevra Therapeutics annual total liabilities?

The current annual total liabilities of ZVRA is $110.46 M

What is the all time high annual total liabilities for Zevra Therapeutics?

Zevra Therapeutics all-time high annual total liabilities is $110.46 M

What is Zevra Therapeutics annual total liabilities year-on-year change?

Over the past year, ZVRA annual total liabilities has changed by +$70.24 M (+174.65%)

What is Zevra Therapeutics quarterly total liabilities?

The current quarterly total liabilities of ZVRA is $121.78 M

What is the all time high quarterly total liabilities for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly total liabilities is $123.42 M

What is Zevra Therapeutics quarterly total liabilities year-on-year change?

Over the past year, ZVRA quarterly total liabilities has changed by +$50.27 M (+70.29%)